Search

Your search keyword '"Turajlic, Samra"' showing total 509 results

Search Constraints

Start Over You searched for: Author "Turajlic, Samra" Remove constraint Author: "Turajlic, Samra"
509 results on '"Turajlic, Samra"'

Search Results

1. Are the Latent Representations of Foundation Models for Pathology Invariant to Rotation?

4. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

5. Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

6. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer

7. Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study

8. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

9. Pervasive chromosomal instability and karyotype order in tumour evolution

19. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment: Including myocarditis and the new entity of non inflammatory left ventricular dysfunction

20. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study

21. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

22. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

23. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

24. Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis

25. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition

27. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

31. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

33. Abstract A007: Representative sampling of invasive breast carcinomas: Interim report from a prospective study (HOLST-F)

35. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

36. Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

37. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

38. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

39. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

40. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

41. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

42. Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.

45. 1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies

46. Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockade

47. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

48. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

49. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

50. Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis

Catalog

Books, media, physical & digital resources